Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1099519.RAjdMQ4Nq6xN6mme4jtWPQj1jG08f8LYgANja0R-zG2iE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1099519.RAjdMQ4Nq6xN6mme4jtWPQj1jG08f8LYgANja0R-zG2iE130_assertion type Assertion NP1099519.RAjdMQ4Nq6xN6mme4jtWPQj1jG08f8LYgANja0R-zG2iE130_head.
- NP1099519.RAjdMQ4Nq6xN6mme4jtWPQj1jG08f8LYgANja0R-zG2iE130_assertion description "[The decreased expression of Wnt/?-Catenin targeting genes, such as cyclin D1, C-myc and survivin, and the inhibition of the activity of the transcription factor (T-cell factor 4, TCF-4) were observed in GL-treated breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1099519.RAjdMQ4Nq6xN6mme4jtWPQj1jG08f8LYgANja0R-zG2iE130_provenance.
- NP1099519.RAjdMQ4Nq6xN6mme4jtWPQj1jG08f8LYgANja0R-zG2iE130_assertion evidence source_evidence_literature NP1099519.RAjdMQ4Nq6xN6mme4jtWPQj1jG08f8LYgANja0R-zG2iE130_provenance.
- NP1099519.RAjdMQ4Nq6xN6mme4jtWPQj1jG08f8LYgANja0R-zG2iE130_assertion SIO_000772 23914993 NP1099519.RAjdMQ4Nq6xN6mme4jtWPQj1jG08f8LYgANja0R-zG2iE130_provenance.
- NP1099519.RAjdMQ4Nq6xN6mme4jtWPQj1jG08f8LYgANja0R-zG2iE130_assertion wasDerivedFrom befree-2016 NP1099519.RAjdMQ4Nq6xN6mme4jtWPQj1jG08f8LYgANja0R-zG2iE130_provenance.
- NP1099519.RAjdMQ4Nq6xN6mme4jtWPQj1jG08f8LYgANja0R-zG2iE130_assertion wasGeneratedBy ECO_0000203 NP1099519.RAjdMQ4Nq6xN6mme4jtWPQj1jG08f8LYgANja0R-zG2iE130_provenance.